Brief: Agile Therapeutics Q3 Net Income USD -799 Thousand
09/11/2023 13:05
Nov 09 (Reuters) - Agile Therapeutics Q3 income from operations USD -4 million. * Q3 revenue USD 6.662 million * Q3 operating expenses USD 8.185 million * Q3 gross profit USD 4.185 million * Q3 basic EPS USD -0.27
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt